Celecoxib · larger labeled portfolio than Atomoxetine
SPL labels Atomoxetine + Celecoxib as minor; Atomoxetine 14 / Celecoxib 16 in that band.
Mechanism on file: Celecoxib can interfere with how your body processes atomoxetine, which may cause the drug to reach toxic levels.
FDA SPL severity: Minor
Atomoxetine + Celecoxib · SPL mechanism field
Celecoxib can interfere with how your body processes atomoxetine, which may cause the drug to reach toxic levels.
Minor band excerpt · Atomoxetine with Celecoxib
Therefore, there is a potential for an in vivo drug interaction with drugs that are metabolized by CYP2D6 (e.g., atomoxetine), and celecoxib may enhance the exposure and toxicity of these drugs.
Atomoxetine · 14 minor + 15 total pairs
- Desipramine minor
- Desvenlafaxine minor
- Diazepam minor
- Dobutamine minor
Celecoxib · 19 SPL pairs (broader portfolio than Atomoxetine)
- Aspirin minor
- Cyclosporine minor
- Diclofenac minor
- Digoxin minor
FDA Drug Labels (SPL) via openFDA. Registry display only. Not medical advice.
Read our methodology - how this data is sourced, computed, and verified.